Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723921 | SCV000203700 | uncertain significance | not provided | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000154060 | SCV000515160 | benign | not specified | 2016-10-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001084773 | SCV000643541 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354361 | SCV002619884 | likely benign | Cardiovascular phenotype | 2020-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000723921 | SCV004150316 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |